Dr. Anveshika Manoj

About

Currently I am working on exploring therapeutic potentials for Prostate Cancer. I am passionate about pushing the boundaries of our understanding of cancer biology to discover innovative treatments and improve patient outcomes. With over 5 years of experience in oncology research, I have honed my skills in molecular biology, data analysis, and cell culture. I thrive in collaborative environments, where interdisciplinary teamwork and cutting-edge research converge to solve complex problems. My goal is to continue advancing the field of cancer research through groundbreaking discoveries and to contribute to the development of new therapeutic strategies that offer hope and healing to those affected by cancer.

I have developed skills in various cell and molecular biology techniques including Western /immunoblotting ; Genomic DNA Isolation; RNA Isolation ; Real time-PCR; Primer Designing; Cell culture (PC3, DU145, Rat Renal Proximal Tubular Epithelial Cells, T HESCs (Endometrial cell line)); Migration assay; Cell viability assay (MTT); Flow Cytometric Analysis- Cell cycle; Apoptosis assay by Flow Cytometry; Clonogenic Assay; Invasion assay; SDS-PAGE; ELISA, ImmunoCytochemistry; Immuno-Histochemistry; PCR-RFLP; Agarose gel electrophoresis; Animal Handling- (Endometriosis Model by surgery, tissue isolation, and processing).

I have beginner skills in computational biology with skills in predicting miRNA targets, functional clustering, STRING analysis, and visualization by Cytoscape 3.9.1.

Employment

• King George's Medical University Senior Research Fellow
  2019 - 2023
• Central Drug Research Institute Project Junior Research Fellow
  2018 - 2019

Education

• King George's Medical University Ph.D (Exploring therapeutic miRNA as a novel network in prostate cancer)
  2019 - 2025
• Banasthali Vidyapith M.Tech
  2016 - 2018
• Banasthali Vidyapith B.Tech
  2012 - 2016

Projects & Funding

Projects & funding information is unavailable.

Publications (9)

• Elucidating the Role of MicroRNA 1827 as Diagnostic Biomarker in Prostate Cancer Progression
  Applied Biochemistry and Biotechnology 2025 DOI: 10.1007/s12010-025-05347-5
  +Save
• Unveiling the potential of emerging microRNA panels as diagnostic biomarkers for prostate cancer: A review
  UroPrecision 2025 DOI: 10.1002/uro2.105
  +Save
• MCP-1 promotes ILK phosphorylation at Ser246 during endometriosis development and affects the pregnancy outcome
  Molecular Human Reproduction 2025 DOI: 10.1093/molehr/gaaf004
  +Save
• Molecular Mechanisms of Preventable Causes of Oral Cancer and Precancer Through Polymorphism in DNA Base Excision Repair Genes in Patients with Tobacco Products Habits
  Journal of Maxillofacial and Oral Surgery 2025 DOI: 10.1007/s12663-024-02294-2
  +Save
• Discovery and Validation of Novel microRNA Panel for Non-Invasive Prediction of Prostate Cancer.
  Cureus 2024 DOI: 10.7759/cureus.58207
  +Save
• Comprehensive cataloging of miR-363 as a therapeutic & non-invasive biomarker of prostate cancer
  Indian Journal of Medical Research 2024 DOI: 10.25259/ijmr_2274_23
  +Save
• Computational Analysis of Differentially Expressed Circulating MicroRNA and Identification of Key Genes in Prostate Cancer
  Indian Journal of Clinical Biochemistry 2024 DOI: 10.1007/s12291-024-01237-5
  +Save
• Corrigendum to “Screening and validation of novel serum panel of microRNA in stratification of prostate cancer” [Prostate Int 11 (2023) 150–158, (S2287888223000326), (10.1016/j.prnil.2023.06.002)]
  Prostate International 2024 DOI: 10.1016/j.prnil.2024.01.001
  +Save
• Screening and validation of novel serum panel of microRNA in stratification of prostate cancer
  Prostate International 2023 DOI: 10.1016/j.prnil.2023.06.002
  +Save